Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9691 USD | +2.20% | -7.70% | +12.03% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 166M | Capitalization | 121M |
---|---|---|---|---|---|
Net income 2024 * | -146M | Net income 2025 * | -138M | EV / Sales 2024 * | 0.83 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.73 x |
P/E ratio 2024 * |
-0.79
x | P/E ratio 2025 * |
-1.17
x | Employees | 325 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.8% |
Latest transcript on Karyopharm Therapeutics Inc.
1 day | +2.20% | ||
1 week | -7.70% | ||
1 month | -5.91% | ||
3 months | -16.46% | ||
6 months | +25.86% | ||
Current year | +12.03% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 19-02-24 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 13-10-02 |
Barry Greene
BRD | Director/Board Member | 60 | 12-12-31 |
Director/Board Member | 59 | 13-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.9691 | +2.20% | 1,244,581 |
24-05-30 | 0.9482 | -1.47% | 838,903 |
24-05-29 | 0.9623 | -3.14% | 2,047,836 |
24-05-28 | 0.9935 | -5.38% | 1,445,280 |
24-05-24 | 1.05 | -3.67% | 939,923 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.03% | 121M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- KPTI Stock